Dr. Kai Joachimsen, MD, MBA

CEO | Bundesverband der Pharmazeutischen Industrie (BPI)

Dr. Kai Joachimsen is a licensed doctor as well as a graduate in business administration. He completed his medical studies in Marburg, Münster, and Vienna. His experimental research was conducted in the field of radiology and cardiology, specifically focusing on magnetic resonance imaging in cardiomyopathies.

Dr. Joachimsen obtained his Master of Business Administration (MBA) from Northwestern University Kellogg in Chicago and WHU in Vallendar. He has held leadership positions in the pharmaceutical industry, including serving as the Head of Marketing & Business Team Respiratory at GlaxoWellcome/GSK, Department Head of Respiratory & Cardiovascular at Boehringer Ingelheim, Business Unit Leader, Head of New Commercial Model, EMEAC Franchise Leader, and Global Franchise Leader at MSD/Merck Inc. in Munich and New Jersey. In 2012, he assumed the sole management of Chiesi GmbH Deutschland and served as CEO in the private equity sector. Since 2018, he has been working at BPI e.V.; since 2019, he has been serving as the Chief Executive Officer and an executive board member.